Literature DB >> 11441809

Properties and biological activities of thioredoxins.

G Powis1, W R Montfort.   

Abstract

The mammalian thioredoxins are a family of small (approximately 12 kDa) redox proteins that undergo NADPH-dependent reduction by thioredoxin reductase and in turn reduce oxidized cysteine groups on proteins. The two main thioredoxins are thioredoxin- 1, a cytosolic and nuclear form, and thioredoxin-2, a mitochondrial form. Thioredoxin-1 has been studied more. It performs many biological actions including the supply of reducing equivalents to thioredoxin peroxidases and ribonucleotide reductase, the regulation of transcription factor activity, and the regulation of enzyme activity by heterodimer formation. Thioredoxin-1 stimulates cell growth and is an inhibitor of apoptosis. Thioredoxins may play a role in a variety of human diseases including cancer. An increased level of thioredoxin-1 is found in many human tumors, where it is associated with aggressive tumor growth. Drugs are being developed that inhibit thioredoxin and that have antitumor activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441809     DOI: 10.1146/annurev.biophys.30.1.421

Source DB:  PubMed          Journal:  Annu Rev Biophys Biomol Struct        ISSN: 1056-8700


  105 in total

1.  The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities.

Authors:  Qing Cheng; William E Antholine; Judith M Myers; Balaraman Kalyanaraman; Elias S J Arnér; Charles R Myers
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Non-animal origin of animal thioredoxin reductases: implications for selenocysteine evolution and evolution of protein function through carboxy-terminal extensions.

Authors:  Sergey V Novoselov; Vadim N Gladyshev
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

3.  Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.

Authors:  Yanfei Yang; Tetsuro Ago; Peiyong Zhai; Maha Abdellatif; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-12-23       Impact factor: 17.367

Review 4.  Mitochondrial thiols in the regulation of cell death pathways.

Authors:  Fei Yin; Harsh Sancheti; Enrique Cadenas
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

5.  Growth hormone alters the glutathione S-transferase and mitochondrial thioredoxin systems in long-living Ames dwarf mice.

Authors:  Lalida Rojanathammanee; Sharlene Rakoczy; Holly M Brown-Borg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-27       Impact factor: 6.053

6.  A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Authors:  A Mukherjee; K Huber; H Evans; N Lakhani; S Martin
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

7.  Thioredoxin-related mechanisms in hyperoxic lung injury in mice.

Authors:  Trent E Tipple; Stephen E Welty; Lynette K Rogers; Thomas N Hansen; Young-Eun Choi; James P Kehrer; Charles V Smith
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

8.  Thioredoxin reductase activity may be more important than GSH level in protecting human lens epithelial cells against UVA light.

Authors:  Vanita A Padgaonkar; Victor R Leverenz; Aparna V Bhat; Sara E Pelliccia; Frank J Giblin
Journal:  Photochem Photobiol       Date:  2015-01-08       Impact factor: 3.421

9.  Expression, purification, crystallization and preliminary X-ray diffraction analysis of mitochondrial thioredoxin Trx3 from Saccharomyces cerevisiae.

Authors:  Rui Bao; Yu-xing Chen; Yaru Zhang; Cong-Zhao Zhou
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-25

10.  TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway.

Authors:  Cheng Zhang; Ming-Xiang Zhang; Ying H Shen; Jared K Burks; Yun Zhang; Jian Wang; Scott A LeMaire; Koichi Yoshimura; Hiroki Aoki; Joseph S Coselli; Xing Li Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.